Oragenics, Inc.OGENNYSE
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +177.07% | +155.68% | -82.63% | -99.84% | -99.76% |
| Weighted Average Shares Diluted Growth | +177.07% | +155.68% | -82.63% | -99.84% | -99.76% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -34.12% | -70.35% | +9.48% | -21.04% | +144.15% |
| Book Value per Share Growth | -82.90% | +0.00% | -69.80% | +0.00% | +133501.61% |
| Debt Growth | +0.32% | +1.86% | +1913.86% | +0.00% | -23.98% |
| R&D Expense Growth | +14.26% | -84.92% | -48.52% | -50.41% | +5.90% |
| SG&A Expenses Growth | +16.94% | -3.65% | -6.23% | -9.63% | +40.73% |